Full history for every metric is available with a Kvantra account
Stock profile
PAREXEL Intl Corp. (PRXL)
Current price
88.08 USD-0.02%
Last close 29 Sep 2017Benchmarks
Key financial summary
Financials in USD| 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | TTM | ||
|---|---|---|---|---|---|---|---|---|
| Total revenue | $m | 1,618 | 1,996 | 2,266 | 2,330 | 2,426 | 2,442 | 2,442 |
| Operating profit | $m | 191 | 191 | |||||
| Net profit | $m | 63 | 96 | 129 | 148 | 155 | 107 | 107 |
| EPS reported | $ | 2.06 | 2.02 | |||||
| Operating cashflow per share | $ | - | 5.95 | |||||
| Capex per share | $ | - | 1.41 | |||||
| FCF per share | $ | - | 4.54 | |||||
| Free cash flow | $m | 234 | 234 | |||||
| Net debt | $m | 369 | 369 | |||||
| Book value equity | $m | 635 | 635 | |||||
| Book value per share | $ | 12.16 | 12.16 | |||||
| Number of shares | m | 52.2 | 52.2 | |||||
| DPS (TTM paid) | $ | 0.00 | 0.00 |
Financial summary
Financials in USD| 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | TTM | ||
|---|---|---|---|---|---|---|---|---|
| Value | ||||||||
| P/E TTM | x | - | - | |||||
| P/B LTM | x | 7.05 | 7.15 | |||||
| P/S LTM | x | 1.83 | 0.00 | |||||
| P/FCF LTM | x | 19.14 | 0.00 | |||||
| EV/EBITDA LTM | x | 17.62 | 1.34 | |||||
| EV/Sales LTM | x | - | 0.15 | |||||
| Earnings Yield LTM | % | - | 2.37% | |||||
| FCF Yield | % | 5.22% | - | |||||
| Quality | ||||||||
| ROE | % | - | 16.93% | |||||
| ROIC | % | - | 8.98% | |||||
| Operating margin | % | - | 7.83% | |||||
| Gross margin | % | - | 7.83% | |||||
| FCF/Sales | % | - | 9.58% | |||||
| Growth and momentum | ||||||||
| EPS Growth YoY | % | -27.97% | -27.97% | |||||
| Sales Growth YoY | % | +0.63% | +0.63% | |||||
| Net Income Growth YoY | % | -30.73% | -30.73% | |||||
| FCF Growth | % | +41.01% | +41.01% | |||||
| Operating Profit Growth | % | -14.64% | -14.64% | |||||
| Dividend and capital structure | ||||||||
| Dividend Yield | % | - | 0.00% | |||||
| Dividend Growth | % | 0.00% | 0.00% | |||||
| Payout Ratio | % | - | 0.00% | |||||
| FCF/Debt | x | 0.35 | 0.35 | |||||
| Net Debt/EBITDA | x | - | 1.34 | |||||
| EBIT/Net interest | x | - | 15.54 | |||||
| Net debt/market cap | % | 8.24% | - | |||||
| Net debt/Equity | x | 0.58 | 0.58 | |||||
| Gross debt/equity | x | 1.06 | 1.06 | |||||
Company overview
No description available.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
PR
PAREXEL Intl Corp. (PRXL)
PRXL · NASDAQ · Healthcare
88.08 USD-0.02%
Benchmarks
Financialsin USD
20152016TTM
Total revenue $m2,4262,4422,442
Operating profit $m191191
Net profit $m155107107
EPS reported $2.062.02
About
No description available.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free